Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kodiak Sciences Inc.(KOD) | 1,059,730 | 533,113 | -526,617 | $41.29M | $50.54M | 10.03% | +$9.25M |
| ABIVAX Société AnonymeADS(ABVX) | 328,635 | 285,909 | -42,726 | $43.35M | $28.44M | 5.64% | -$14.91M |
| Vaxcyte, Inc.(PCVX) | 388,682 | 400,465 | +11,783 | $22.59M | $22.79M | 4.52% | +$192.4K |
| Arcus Biosciences, Inc.(RCUS) | 504,559 | 734,559 | +230,000 | $15.56M | $18.97M | 3.76% | +$3.42M |
| Celldex Therapeutics, Inc.(CLDX) | 478,500 | 518,500 | +40,000 | $17.80M | $16.80M | 3.33% | -$1.00M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 117,500 | 561,459 | +443,959 | $2.11M | $16.34M | 3.24% | +$14.23M |
| Pharvaris N V COM | 308,856 | 502,372 | +193,516 | $10.68M | $15.94M | 3.16% | +$5.25M |
| Vera Therapeutics, Inc.CL A(VERA) | 310,000 | 400,000 | +90,000 | $13.30M | $12.92M | 2.56% | -$386.1K |
| Alto Neuroscience, Inc.(ANRO) | 407,338 | 482,338 | +75,000 | $10.75M | $12.31M | 2.44% | +$1.56M |
| Cogent Biosciences, Inc.(COGT) | 370,084 | 370,084 | 0 | $14.32M | $11.85M | 2.35% | -$2.47M |
| ANI Pharmaceuticals, Inc.(ANIP) | 272,085 | 149,065 | -123,020 | $22.52M | $10.83M | 2.15% | -$11.69M |
| Enliven Therapeutics Inc | 126,541 | 232,055 | +105,514 | $6.42M | $10.64M | 2.11% | +$4.22M |
| Maze Therapeutics, Inc.(MAZE) | 378,999 | 301,402 | -77,597 | $11.31M | $8.19M | 1.63% | -$3.12M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 807,874 | 594,666 | -213,208 | $13.24M | $7.98M | 1.58% | -$5.26M |
| Cue Biopharma, Inc.(CUE) | 104,364 | 290,633 | +186,269 | $3.29M | $7.52M | 1.49% | +$4.22M |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 809,741 | 809,741 | 0 | $5.35M | $7.37M | 1.46% | +$2.02M |
| Tectonic Therapeutic, Inc.(TECX) | 205,837 | 306,338 | +100,501 | $7.08M | $7.13M | 1.42% | +$59.0K |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 522,765 | +522,765 | $0 | $7.04M | 1.40% | +$7.04M |
| Monopar Therapeutics Inc.(MNPR) | 47,861 | 86,761 | +38,900 | $4.43M | $6.91M | 1.37% | +$2.48M |
| C4 Therapeutics, Inc.(CCCC) | 2,433,000 | 1,933,000 | -500,000 | $11.36M | $6.44M | 1.28% | -$4.93M |
| Alpha Cognition Inc. Common Stock(ACOG) | 836,259 | 701,259 | -135,000 | $6.04M | $6.31M | 1.25% | +$273.5K |
| Immunome, Inc.(IMNM) | 60,000 | 285,000 | +225,000 | $1.27M | $6.13M | 1.22% | +$4.86M |
| Jade Biosciences Inc | 427,349 | 427,349 | 0 | $9.50M | $6.00M | 1.19% | -$3.49M |
| Helus Pharma Inc(HELP) | 132,153 | 487,575 | +355,422 | $873.5K | $5.99M | 1.19% | +$5.12M |
| Faeth Therapeutics, Inc.(FTH) | 35,386 | 199,694 | +164,308 | $884.6K | $5.94M | 1.18% | +$5.05M |
| Damora Therapeutics Inc | 0 | 275,710 | +275,710 | $0 | $5.87M | 1.16% | +$5.87M |
| Freenome Inc | 0 | 362,626 | +362,626 | $0 | $5.71M | 1.13% | +$5.71M |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 3,425,930 | 3,425,930 | 0 | $6.37M | $5.69M | 1.13% | -$685.2K |
| Cardiol Therapeutics Inc.CL A(CRDL) | 3,325,000 | 3,325,000 | 0 | $3.52M | $5.52M | 1.09% | +$2.00M |
| Relmada Therapeutics, Inc.(RLMD) | 2,148,359 | 1,448,359 | -700,000 | $14.87M | $5.46M | 1.08% | -$9.41M |
| Pelthos Therapeutics Inc.(PTHS) | 256,598 | 256,598 | 0 | $7.25M | $5.39M | 1.07% | -$1.86M |
| Ovid Therapeutics Inc.(OVID) | 2,269,704 | 2,119,704 | -150,000 | $6.11M | $5.28M | 1.05% | -$827.4K |
| Spruce Biosciences Inc | 121,356 | 101,356 | -20,000 | $6.55M | $4.92M | 0.98% | -$1.63M |
| Vor Biopharma Inc.(VOR) | 0 | 250,000 | +250,000 | $0 | $4.77M | 0.95% | +$4.77M |
| Vogenx Inc | 0 | 208,836 | +208,836 | $0 | $4.76M | 0.94% | +$4.76M |
| Viridian Therapeutics, Inc.(VRDN) | 425,000 | 225,000 | -200,000 | $7.81M | $4.63M | 0.92% | -$3.17M |
| Bright Minds Biosciences Inc.(DRUG) | 88,951 | 88,951 | 0 | $6.24M | $4.43M | 0.88% | -$1.81M |
| Zura Bio LimitedCL A(ZURA) | 1,218,492 | 1,018,492 | -200,000 | $7.19M | $4.24M | 0.84% | -$2.95M |
| Inventiva S.A.ADS(IVA) | 1,129,101 | 1,129,101 | 0 | $4.15M | $4.22M | 0.84% | +$62.7K |
| Cumberland Pharmaceuticals Inc.(CPIX) | 503,153 | 503,153 | 0 | $3.26M | $3.94M | 0.78% | +$679.3K |
| Septerna, Inc.(SEPN) | 0 | 100,047 | +100,047 | $0 | $3.91M | 0.78% | +$3.91M |
| Rezolute, Inc.(RZLT) | 935,012 | 935,012 | 0 | $4.86M | $3.87M | 0.77% | -$991.1K |
| Amanat Acquisition CorpCL A | 150,000 | 349,836 | +199,836 | $1.52M | $3.73M | 0.74% | +$2.20M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 0 | 912,906 | +912,906 | $0 | $3.69M | 0.73% | +$3.69M |
| Ocugen, Inc.(OCGN) | 3,962,972 | 3,562,972 | -400,000 | $6.06M | $3.67M | 0.73% | -$2.39M |
| Alector Inc | 1,982,606 | 1,982,606 | 0 | $3.99M | $3.67M | 0.73% | -$317.2K |
| Olema Oncology, Inc.(OLMA) | 383,281 | 383,281 | 0 | $4.79M | $3.31M | 0.66% | -$1.48M |
| Silence Therapeutics plcADS(SLN) | 830,784 | 821,790 | -8,994 | $1.83M | $3.29M | 0.65% | +$1.46M |
| Ginkgo Bioworks Holdings, Inc.CL A(DNA) | 0 | 250,000 | +250,000 | $0 | $3.21M | 0.64% | +$3.21M |
| Quince Therapeutics Inc | 72,251 | 95,652 | +23,401 | $1.31M | $2.97M | 0.59% | +$1.65M |
| Q32 Bio Inc.(QTTB) | 430,000 | 345,000 | -85,000 | $5.48M | $2.85M | 0.57% | -$2.63M |
| Arvinas, Inc.(ARVN) | 358,257 | 358,257 | 0 | $2.98M | $2.77M | 0.55% | -$206.0K |
| Connect Biopharma Holdings LimitedSHS(CNTB) | 4,538,534 | 2,235,534 | -2,303,000 | $10.80M | $2.46M | 0.49% | -$8.34M |
| Rein Therapeutics Inc.(RNTX) | 2,950,000 | 2,950,000 | 0 | $3.07M | $2.37M | 0.47% | -$696.2K |
| Kazia Therapeutics LimitedADS(KZIA) | 396,201 | 246,201 | -150,000 | $5.58M | $2.36M | 0.47% | -$3.22M |
| Acumen Pharmaceuticals, Inc.(ABOS) | 1,053,797 | 1,053,797 | 0 | $2.81M | $2.34M | 0.46% | -$474.2K |
| Invivyd, Inc.(IVVD) | 2,656,570 | 2,656,570 | 0 | $2.32M | $2.31M | 0.46% | -$6.1K |
| Acadia Pharmaceuticals Inc | 28,099 | 112,000 | +83,901 | $710.9K | $2.26M | 0.45% | +$1.55M |
| ProMIS Neurosciences, Inc.(PMN) | 205,000 | 205,000 | 0 | $2.70M | $2.22M | 0.44% | -$473.6K |
| Crescent Biopharma, Inc.(CBIO) | 0 | 150,061 | +150,061 | $0 | $2.19M | 0.43% | +$2.19M |
| Obsidian Therapeutics Inc | 0 | 158,942 | +158,942 | $0 | $2.18M | 0.43% | +$2.18M |
| Capricor Therapeutics, Inc.(CAPR) | 604,215 | 229,215 | -375,000 | $14.55M | $2.17M | 0.43% | -$12.38M |
| Delcath Systems, Inc.(DCTH) | 185,667 | 135,667 | -50,000 | $2.34M | $2.17M | 0.43% | -$170.9K |
| 4d Molecular Therapeutics In | 0 | 150,037 | +150,037 | $0 | $2.15M | 0.43% | +$2.15M |
| Praxis Precision Medicines, Inc.(PRAX) | 72,842 | 6,942 | -65,900 | $24.39M | $2.02M | 0.40% | -$22.37M |
| Neuronetics, Inc.(STIM) | 701,182 | 810,182 | +109,000 | $911.5K | $1.90M | 0.38% | +$984.3K |
| Biohaven Ltd.(BHVN) | 748,181 | 133,181 | -615,000 | $11.13M | $1.78M | 0.35% | -$9.35M |
| Lexeo Therapeutics, Inc.(LXEO) | 513,011 | 513,011 | 0 | $2.39M | $1.73M | 0.34% | -$654.1K |
| Verastem, Inc.(VSTM) | 213,865 | 213,865 | 0 | $817.0K | $1.72M | 0.34% | +$904.6K |
| Journey Medical Corporation(DERM) | 251,436 | 251,436 | 0 | $1.78M | $1.72M | 0.34% | -$60.3K |
| Immunic, Inc.(IMUX) | 67,464 | 182,464 | +115,000 | $1.04M | $1.70M | 0.34% | +$660.0K |
| PepGen Inc.(PEPG) | 447,165 | 693,539 | +246,374 | $804.9K | $1.68M | 0.33% | +$873.5K |
| Fulcrum Therapeutics, Inc.(FULC) | 1,049,161 | 449,161 | -600,000 | $3.84M | $1.66M | 0.33% | -$2.18M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 65,000 | +65,000 | $0 | $1.42M | 0.28% | +$1.42M |
| Avalo Therapeutics, Inc.(AVTX) | 90,183 | 90,183 | 0 | $1.67M | $1.38M | 0.27% | -$284.1K |
| Cabaletta Bio, Inc.(CABA) | 700,000 | 700,000 | 0 | $2.18M | $1.34M | 0.27% | -$833.0K |
| Tarsus Pharmaceuticals, Inc.(TARS) | 31,166 | 16,858 | -14,308 | $1.96M | $1.33M | 0.26% | -$636.4K |
| uniQure N.V.SHS(QURE) | 0 | 49,800 | +49,800 | $0 | $1.20M | 0.24% | +$1.20M |
| Palatin Technologies, Inc.(PTN) | 0 | 130,000 | +130,000 | $0 | $1.15M | 0.23% | +$1.15M |
| iBio, Inc.(IBIO) | 957,062 | 957,062 | 0 | $1.67M | $1.13M | 0.22% | -$545.5K |
| Lipocine Inc.(LPCN) | 508,556 | 508,556 | 0 | $1.30M | $1.12M | 0.22% | -$183.1K |
| Pliant Therapeutics, Inc.(PLRX) | 1,000,000 | 1,000,000 | 0 | $1.14M | $1.08M | 0.21% | -$60.0K |
| DBV Technologies S.A.ADS(DBVT) | 525,000 | 453,374 | -71,626 | $1.69M | $1.07M | 0.21% | -$625.6K |
| Harrow, Inc.(HROW) | 135,775 | 33,275 | -102,500 | $5.77M | $1.02M | 0.20% | -$4.74M |
| Quoin Pharmaceuticals, Ltd.ADS(QNRX) | 211,538 | 211,538 | 0 | $1.02M | $964.6K | 0.19% | -$59.2K |
| Jasper Therapeutics, Inc.(JSPR) | 24,093 | 1,342,626 | +1,318,533 | $10.1K | $778.7K | 0.15% | +$768.6K |
| Neumora Therapeutics, Inc.(NMRA) | 1,278,408 | 1,278,408 | 0 | $2.17M | $762.2K | 0.15% | -$1.41M |
| CNS Pharmaceuticals, Inc.(CNSP) | 135,830 | 135,830 | 0 | $649.3K | $719.9K | 0.14% | +$70.6K |
| Kalaris Therapeutics, Inc.(KLRS) | 360,000 | 248,257 | -111,743 | $1.47M | $717.5K | 0.14% | -$747.7K |
| EyePoint, Inc.(EYPT) | 0 | 205,056 | +205,056 | $0 | $670.5K | 0.13% | +$670.5K |
| AEON Biopharma, Inc.CL A(AEON) | 0 | 2,203,406 | +2,203,406 | $0 | $661.0K | 0.13% | +$661.0K |
| Tcgx Acquisition CorpCL A | 0 | 50,000 | +50,000 | $0 | $625.5K | 0.12% | +$625.5K |
| Fractyl Health, Inc.(GUTS) | 1,100,000 | 1,100,000 | 0 | $873.8K | $598.8K | 0.12% | -$275.0K |
| Foghorn Therapeutics Inc.(FHTX) | 0 | 160,000 | +160,000 | $0 | $571.2K | 0.11% | +$571.2K |
| Adlai Nortye Group Ltd.ADS(ANL) | 33,899 | 33,899 | 0 | $389.8K | $542.4K | 0.11% | +$152.5K |
| Palisade Bio, Inc.(PALI) | 750,000 | 400,000 | -350,000 | $1.57M | $540.0K | 0.11% | -$1.03M |
| Equillium, Inc.(EQ) | 303,555 | 303,555 | 0 | $971.4K | $493.3K | 0.10% | -$478.1K |
| Sionna Therapeutics, Inc.(SION) | 0 | 85,300 | +85,300 | $0 | $448.7K | 0.09% | +$448.7K |
| Immatics N.V.SHS(IMTX) | 48,569 | 48,569 | 0 | $492.0K | $426.4K | 0.08% | -$65.6K |
| Lyell Immunopharma, Inc.(LYEL) | 41,081 | 41,081 | 0 | $577.2K | $402.2K | 0.08% | -$175.0K |